Advertisements

Catabasis Pharmaceuticals Inc. (CATB) Stock Quote

Detailed Quote for Catabasis Pharmaceuticals Inc. (CATB)
$ 1.56   -0.04 (-2.50%) Volume: 1.53m 4:00 PM EST 20-Feb-2018
After Hours:  $ 1.55   -0.01 (-0.64%) Volume: 1,000 5:59 PM EST 20-Feb-2018
Today 5d 1m 3m 1y more
Last Price
1.56
Change $
0.04
Change %
2.50%
Tick
  
Bid
1.46
Bid Size
6,000
Ask
1.79
Ask Size
1,000
Open
1.60
High
1.67
Low
1.5032
Prev Close
1.60
Last Trade
02/20/18
Volume
1.53m
52 Wk Hi
3.77999997
52 Wk Low
1.09000003
Market Cap
36.01m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
23,083,177
EPS (TTM)
-1.49
PE Ratio
N/A
Exchange
NSD
News and Media for Catabasis Pharmaceuticals Inc. (CATB)
Sector News | Topic News
News for Catabasis Pharmaceuticals Inc. (CATB)
Fri, Feb 16, 2018
12:44 PM Midday Gainers / Losers (2/16/2018) - SeekingAlpha
Thu, Feb 15, 2018
12:03 PM It's Time To Invest In Catabasis Pharmaceuticals Following Impressive Phase 2 DMD Data - SeekingAlpha
8:01 AM Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration - SeekingAlpha
Wed, Feb 14, 2018
8:30 AM Today's Research Reports on Trending Tickers: Catabasis Pharmaceuticals and ImmunoCellular Therapeutics - ACCESSWIRE IA
Tue, Feb 13, 2018
12:50 PM Midday Gainers / Losers (2/13/2018) - SeekingAlpha
10:02 AM Catabasis Pharma's edasalonexent shows positive effect in mid-stage DMD study; shares up 62% - SeekingAlpha
9:24 AM Premarket Gainers as of 9:05 am (02/13/2018) - SeekingAlpha
8:00 AM Catabasis Pharmaceuticals Reports Edasalonexent Preserved Muscle Function and Substantially Slowed Duchenne Muscular Dystrophy Disease Progression Through More Than One Year of Treatment - Business Wire
Tue, Jan 02, 2018
3:44 PM Solid Biosciences on deck for IPO - SeekingAlpha
Tue, Dec 19, 2017
8:04 AM Your Daily Pharma Scoop: Ultragenyx Sells Voucher, Regeneron Announces Collaboration, Madrigal Offering - SeekingAlpha
Wed, Dec 06, 2017
2:00 AM Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day - GlobeNewswire
Tue, Nov 21, 2017
8:00 AM Catabasis Pharmaceuticals\u00A0to Present at 29th Annual Piper Jaffray Healthcare Conference - Business Wire
Mon, Nov 20, 2017
9:24 AM Premarket Gainers as of 9:05 am - SeekingAlpha
9:06 AM Premarket analyst action - healthcare - SeekingAlpha
Mon, Nov 13, 2017
8:20 AM Analysis: Positioning to Benefit within Catabasis, Flowserve, MGIC Investment, Arrowhead, Silver Spring, and Live Nation - Research Highlights Growth, Revenue, and Consolidated Results - GlobeNewswire
Thu, Nov 09, 2017
11:09 PM Catabasis Pharmaceuticals' (CATB) CEO Jill Milne on Q3 2017 Results - Earnings Call Transcript - SeekingAlpha
4:23 PM Catabasis Pharmaceuticals beats by $0.02 - SeekingAlpha
4:10 PM Catabasis Pharmaceuticals Reports Third Quarter 2017 Financial Results and Reviews Business Progress - Business Wire
Wed, Nov 08, 2017
5:35 PM Notable earnings after Thursday's close - SeekingAlpha
12:01 PM Sarepta Therapeutics Will Continue To Ride High On EXONDYS 51's Success In 2017 - SeekingAlpha
More News for CATB >>

Tags for Catabasis Pharmaceuticals Inc.

Research stocks or mutual funds related to Catabasis Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to CATB. The keywords below have been associated to CATB by either user submission or electronic means.